Literature DB >> 14499262

Granzyme B: pro-apoptotic, antiviral and antitumor functions.

Joseph A Trapani1, Vivien R Sutton.   

Abstract

Granzyme B is a caspase-like serine protease that is released by cytotoxic lymphocytes to kill virus-infected and tumor cells. Major recent advances in our understanding of granzyme B biochemistry, biology and function include an appreciation of its uptake into and trafficking within target cells, a thorough dissection of how cell death is triggered, and the identification of the serpin protease inhibitor PI-9, which regulates its function in lymphocytes and in other cells. The roles that granzyme B plays in human pathologies, such as transplant rejection, viral immunity and particularly tumor immune surveillance, remain a topic for vigorous debate and conjecture. The recent discovery of a triply mutated human granzyme B allele, whose product is predicted to possess a reduced capacity to induce cell death, opens the way for major progress in these areas in coming years.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14499262     DOI: 10.1016/s0952-7915(03)00107-9

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  72 in total

1.  Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro.

Authors:  Li-Hong Lv; Yun-Le Wan; Yan Lin; Wei Zhang; Mei Yang; Guo-Lin Li; Hao-Ming Lin; Chang-Zhen Shang; Ya-Jin Chen; Jun Min
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

2.  Probing the efficiency of proteolytic events by positional proteomics.

Authors:  Kim Plasman; Petra Van Damme; Dion Kaiserman; Francis Impens; Kimberly Demeyer; Kenny Helsens; Marc Goethals; Phillip I Bird; Joël Vandekerckhove; Kris Gevaert
Journal:  Mol Cell Proteomics       Date:  2010-11-03       Impact factor: 5.911

3.  The major human and mouse granzymes are structurally and functionally divergent.

Authors:  Dion Kaiserman; Catherina H Bird; Jiuru Sun; Antony Matthews; Kheng Ung; James C Whisstock; Philip E Thompson; Joseph A Trapani; Phillip I Bird
Journal:  J Cell Biol       Date:  2006-11-20       Impact factor: 10.539

4.  Granule-mediated killing by granzyme B and perforin requires a mannose 6-phosphate receptor and is augmented by cell surface heparan sulfate.

Authors:  Kirstin Veugelers; Bruce Motyka; Ing Swie Goping; Irene Shostak; Tracy Sawchuk; R Chris Bleackley
Journal:  Mol Biol Cell       Date:  2005-11-09       Impact factor: 4.138

5.  Enhancement of CD8 T-cell function through modifying surface glycoproteins in young and old mice.

Authors:  Amir A Sadighi Akha; Scott B Berger; Richard A Miller
Journal:  Immunology       Date:  2006-10       Impact factor: 7.397

Review 6.  Death by a thousand cuts: granzyme pathways of programmed cell death.

Authors:  Dipanjan Chowdhury; Judy Lieberman
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

7.  Distinct profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage, and antigen exposure.

Authors:  Alexandre Harari; Felicitas Bellutti Enders; Cristina Cellerai; Pierre-Alexandre Bart; Giuseppe Pantaleo
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

8.  Cationic sites on granzyme B contribute to cytotoxicity by promoting its uptake into target cells.

Authors:  Catherina H Bird; Jiuru Sun; Kheng Ung; Diana Karambalis; James C Whisstock; Joseph A Trapani; Phillip I Bird
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

9.  Construction and characterization of novel, completely human serine protease therapeutics targeting Her2/neu.

Authors:  Yu Cao; Khalid A Mohamedali; John W Marks; Lawrence H Cheung; Walter N Hittelman; Michael G Rosenblum
Journal:  Mol Cancer Ther       Date:  2013-03-14       Impact factor: 6.261

10.  Granzyme B production distinguishes recently activated CD8(+) memory cells from resting memory cells.

Authors:  Tobias M Nowacki; Stefanie Kuerten; Wenji Zhang; Carey L Shive; Christian R Kreher; Bernhard O Boehm; Paul V Lehmann; Magdalena Tary-Lehmann
Journal:  Cell Immunol       Date:  2007-09-07       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.